The Efficacy and Safety of Nicorandil for Periprocedural Myocardial Injury in Patients Undergoing PCI: A Meta-Analysis.

Journal of Interventional Cardiology
Yuanxi LuQiwu Wang

Abstract

To evaluate the efficacy and safety of nicorandil for periprocedural myocardial injury in patients undergoing PCI through meta-analysis of randomized controlled trials. We analyzed the clinical data of patients including the incidence of periprocedural myocardial injury (PMI) and major adverse cardiovascular events (MACE) from selected articles. RCTs were retrieved from medical literature databases. RR and 95% confidence intervals (CI) were calculated to compare the endpoints. In total, 15 articles (16 trial comparisons) were retrieved which contained 2221 patients. In general, 1130 patients (50.9%) were randomized to the experimental group, whereas 1091 patients (49.1%) were randomized to the control group. The result showed that nicorandil significantly reduced the incidence of PMI and MACE after PCI compared to the control group. Overall, early use of nicorandil in patients undergoing percutaneous coronary intervention (PCI) was associated with a significant reduction of PMI and MACE.

References

Feb 26, 2005·Circulation Journal : Official Journal of the Japanese Circulation Society·Ju Han KimJung Chaee Kang
Dec 13, 2005·International Journal of Cardiology·Masaaki MurakamiYasushi Shiratori
Dec 18, 2007·International Journal of Cardiology·Ryan G SchraleA P Banning
Jul 23, 2009·BMJ : British Medical Journal·David MoherUNKNOWN PRISMA Group
Sep 23, 2010·Vascular Health and Risk Management·Melissa A Daubert, Allen Jeremias
Jan 25, 2014·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Atsushi HirohataTohru Ohe
Sep 25, 2014·Anadolu Kardiyoloji Dergisi : AKD = the Anatolian Journal of Cardiology·Jing YangXue Geng
Jun 18, 2016·Cardiovascular Drugs and Therapy·Jason M Tarkin, Juan Carlos Kaski
Nov 17, 2016·Arquivos brasileiros de cardiologia·Sajad JeddiAsghar Ghasemi
May 18, 2018·Circulation Journal : Official Journal of the Japanese Circulation Society·Shin Ito, Masafumi Kitakaze
Aug 30, 2019·BMJ : British Medical Journal·Jonathan A C SterneJulian P T Higgins

❮ Previous
Next ❯

Software Mentioned

Stata

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.